Overweight and obesity are a threat to health, longevity and quality of life. With the growing trend of using atypical antipsychotics for various psychiatric disorders, concern regarding adverse effects has shifted from extrapyramidal side effects to weight gain and metabolic abnormalities. In this review, the author analyses the extent of the problem, the evidence base for using metformin to counteract the weight gain, and prescribing advice for using metformin effectively
Introduction: Patients living with schizophrenia have a marked risk of clinically significant weight...
Obesity is associated with considerable morbidity and decreased life expectancy. Weight gain is a co...
Massachusetts College of Pharmacy and Health Sciences, Boston, USA, The 8th International Medical C...
Abstract Background Most antipsychotics are associated with weight gain and other metabolic complica...
Weight gain and metabolic disturbances (ie, obesity and diabetes) are common side effects of second-...
Background: Antipsychotic drugs are used in treatment of psychological and neurological disorders. T...
Background: Psychiatric patients requiring therapy with antipsychotics have a greater incidence of b...
Recommend metformin 250mg 3 times a day, along with lifestyle modifications, to promote weight loss ...
The purpose of this study was to determine whether metformin promotes weight loss in overweight out-...
Background: Antipsychotic drugs may lead to side effects such as obesity, diabetes, dyslipidemia, an...
Background: Antipsychotic drugs may lead to side effects such as obesity, diabetes, dyslipidemia, an...
Background: Weight gain is a potentially concerning side effect of second-generation antipsychotics...
Background: Antipsychotic-induced Weight Gain (AiWG) is a debilitating and common adverse effect of ...
Few studies have compared the effect of Metformin treatment on metabolic parameters in atypical anti...
Objectives: There is considerable evidence that metformin reduces weight gain associated with antips...
Introduction: Patients living with schizophrenia have a marked risk of clinically significant weight...
Obesity is associated with considerable morbidity and decreased life expectancy. Weight gain is a co...
Massachusetts College of Pharmacy and Health Sciences, Boston, USA, The 8th International Medical C...
Abstract Background Most antipsychotics are associated with weight gain and other metabolic complica...
Weight gain and metabolic disturbances (ie, obesity and diabetes) are common side effects of second-...
Background: Antipsychotic drugs are used in treatment of psychological and neurological disorders. T...
Background: Psychiatric patients requiring therapy with antipsychotics have a greater incidence of b...
Recommend metformin 250mg 3 times a day, along with lifestyle modifications, to promote weight loss ...
The purpose of this study was to determine whether metformin promotes weight loss in overweight out-...
Background: Antipsychotic drugs may lead to side effects such as obesity, diabetes, dyslipidemia, an...
Background: Antipsychotic drugs may lead to side effects such as obesity, diabetes, dyslipidemia, an...
Background: Weight gain is a potentially concerning side effect of second-generation antipsychotics...
Background: Antipsychotic-induced Weight Gain (AiWG) is a debilitating and common adverse effect of ...
Few studies have compared the effect of Metformin treatment on metabolic parameters in atypical anti...
Objectives: There is considerable evidence that metformin reduces weight gain associated with antips...
Introduction: Patients living with schizophrenia have a marked risk of clinically significant weight...
Obesity is associated with considerable morbidity and decreased life expectancy. Weight gain is a co...
Massachusetts College of Pharmacy and Health Sciences, Boston, USA, The 8th International Medical C...